Acromegaly Treatment Market Explore Future Growth 2018-2026 by Global Top Players – Pfizer, Novartis Pharma AG, GlaxoSmithKline, Aegis Therapeutics, Antisense Therapeutics, Crinetics Pharmaceuticals Inc, Dauntless Pharmaceuticals, Ipsen Biopharmaceutica

Coherent Market Insights has announced the addition of the “Acromegaly Treatment Market Size Status and Forecast 2026”, The report classifies the global Acromegaly Treatment Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

This report studies the global Acromegaly Treatment Speaker market, analyzes and researches the Acromegaly Treatment Speaker development status and forecast in North America, Europe, Asia Pacific, Latin America and Rest of the World. This report focuses on the top players in global market, like Pfizer, Novartis Pharma AG, GlaxoSmithKline, Aegis Therapeutics, Antisense Therapeutics, Crinetics Pharmaceuticals Inc, Dauntless Pharmaceuticals, Ipsen Biopharmaceuticals

Request a sample copy : https://www.coherentmarketinsights.com/insight/request-sample/1477

Acromegaly is a non-preventable disease, early detection of the disease will help to cure the disease symptoms. Increasing awareness to differentiate between acromegaly and other disorders like gigantism, Marfan syndrome, and Pachydermoperiostosis, and further detecting the symptoms and diagnosing it will help in propelling the acromegaly treatment market growth.

Acromegaly Awareness Day was celebrated on November 1, 2017 for the first time by World Alliance of Pituitary Organization (WAPO) and Pituitary Network Association to increase awareness on diagnosing the symptoms of this disease without any delay. Some foundation provided financial assistance to medicare patients suffering with acromegaly. For instance, in December 2017, HealthWell Foundation launched a new fund scheme where it provided a fund of US$ 10,000 for a 12-month grant to acromegaly patients who have annual household incomes up to 400 percent of the federal poverty level. Such funding programs will provide financial ease to the patients suffering from acromegaly, which in turn will propel growth of acromegaly treatment market. In 2017, Crinetics Pharmaceuticals, Inc. was awarded Phase IIB Small Business Innovation Research (SBIR) grant of up to US$ 2.8 million from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) for the development of company’s orally-available, non-peptide somatostatin agonist drug candidate, CRN00808 that can be used for the treatment of acromegaly.

By Disease Type:

Ectopic Acromegaly
Pseudo Acromegaly

By Drug Class:

Somatostatin Analogs (SSAs)
Somatuline Depot (Lanreotide)
Others SSAs
Dopamine Agonists (DAs)
Bromocriptine Mesylate (Parlodel)
Others DAs
Growth Hormone Receptor Antagonist (GHRAs)
Somavert (Pegvisomant)

By Route of Administration:

Oral
Parenteral

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Untreated acromegaly leads to serious and life threating complications such as cardiomyopathy and ventricular arrhythmia. Blood test to measure levels of growth hormones or insulin-like growth factor and imaging of tumors through MRI scan and CT scan are commonly used diagnostic approaches to detect acromegaly. Some medications are 90% effective in shrinking tumor, however, success rate of type of treatment varies based on age, health or medical history of patients. According to the American Society of Clinical Oncology (ASCO), 14,230 individuals of the U.S. were diagnosed with pituitary gland tumor in 2017, of which majority are benign tumor. Furthermore, in 2017, the National Organization for Rare Disorders estimated the prevalence rate of acromegaly as 50-70 person per million and 3 new cases occurs per million every year, which is expected to increase the demand for acromegaly treatment market.

Else place an Inquire before Purchase “Acromegaly Treatment Market Size, Status and Forecast 2026 : https://www.coherentmarketinsights.com/insight/talk-to-analyst/1477

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.